Pharmaceutical Supply for Indian Army Jalandhar City Operations

This tender invites bids for the supply of a comprehensive range of pharmaceutical products to the Department of Military Affairs, under the Ministry of Defence. The bid, numbered GEM/2026/B/8032511, is initiated by the Indian Army and is open from 23-09-2026 at 4:06 PM until 14-10-2026 at 6:00 PM. The procurement encompasses a significant total quantity of 51,160 units across various critical item categories. These include, but are not limited to, Tab Dydrogesterone 10 mg, Tab Doxylamine succinate 10mg USP plus Pyridoxine Hydrochloride 10 mg IP, Inj Enoxaparin 20 mg per 0.2 ml, Tab Letrozole 2.5mg, Cap Evening Primrose Oil 500 Mg Soft Gel, NorEthisterone 5 mg Tab, Tab Melatonin 3 MG Tab plus CoQ10 100 mg plus Micronised DHEA 75 mg SR, Cap Natural Micronised Progesterone 200 mg, Cream Oestrogen Concentration 0.06 percent to 0.1 percent, Oestrogen Conjugated 0.625 mg Tab, Clindamycin, Clotrimazole, and Tinidazole Soft Capsules, Tab Clomiphene Citrate 50 mg, Tab Mifepristone 200 mg, Tab Levonorgestrel 0.25 mg plus Ethinylestradiol, Tab Antispasmodic containing Mefenamic Acid 250 mg, Sachet L-arginine sachet of 5 gm, Tab Cabergoline 0.5mg, and Tab Dehydroepiandrosterone 75 mg SR (DHEA). Prospective bidders are invited to submit their proposals to meet the substantial demand for these essential medical supplies, addressing the requirements of the Indian Army operations based in JALANDHAR CITY.